Spanish
Argentina— The Argentine government repealed a 2012 regulation governing the granting of pharmaceutical patents, introducing a more flexible scheme for their approval.
The measure seeks to promote innovation and attract investment, facilitating the arrival of new drugs to the market. However, specialists warn that it could extend the commercial exclusivity of certain drugs, with possible effects on their prices and access.
We remind you to read:They commemorate World Youth Rheumatology Day this March 18th
The new framework includes provisions to avoid immediate impacts on already available medications, while reopening the debate on the balance between intellectual property and public health in the country. Analysts in the sector point out that the real impact will depend on the implementation and the role of regulatory bodies, especially in ensuring that greater patent protection does not limit competition or affect the availability of essential treatments.
